Used in pharmaceutical research for its potential anabolic effects with reduced androgenic activity, making it a candidate for muscle-wasting conditions without significant hormonal side effects. Investigated for treating osteoporosis, sarcopenia, and other degenerative muscle disorders. Shows tissue-selective action, primarily targeting muscle and bone while minimizing impact on prostate and other sensitive tissues. Currently in experimental stages, not approved for clinical use.